Skip to main content
Home
Search Help
  • Topics
  • Directory
  • Resources
    • Research Tools
    • ELSI Publications
    • ELSIhub Collections
    • ELSI Congresses
    • Resources for Educators
    • SNAPSHOTs
    • Additional Resources
    • Videos
    • Jobs
  • Funding
    • Funding Opportunities
    • ELSI Grant Abstracts
    • Training Videos
    • Additional Funding Resources
    • Funding FAQs
  • News & Events
    • ELSI Friday Forum
    • ELSIconversations
    • ELSI Journal Club
    • ELSIHub News
    • Events
    • TraineeHub
    • In the Media
    • Videos
    • Newsletter
    • Jobs
  • About
    • Welcome
    • CERA FAQs
    • What is ELSI Research?
    • Leadership & Organization
    • CERA Working Groups
    • Accessibility and Usability
    • Contact Us
  • Contribute Content
Twitter Vimeo LinkedIn ELSIhub calendar of events Subscribe to our newsletter Instagram
+ Add Listing
  • + Login
  • + Register
Search Help

After 44 days, Kendric Cromer, 12, left the hospital. While his family feels fortunate that he was the first to receive a treatment, their difficult experiences hint at what others will be up against.

Link
https://www.nytimes.com/2024/10/21/health/sickle-cell-disease-gene-therapy-pati…
Source
The New York Times
Date
Mon, 10/21/2024 - 12:00
Keywords
Sickle Cell
gene therapy

Newsletter

Sign up to receive the latest updates from ELSIhub.

Home
  • Privacy Policy
  • Terms of Use
  • Accessibility
Main contact:
[email protected]
Media contact:
[email protected]
Follow Us:
VimeoTwitter

ELSIhub is financially supported by the National Human Genome Research Institute at the National Institutes of Health (U24HG010733). It is managed at Stanford and Columbia Universities in partnership with the Hastings Center and Case Western Reserve University.

Tell us anything